search
Back to results

Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation

Primary Purpose

Cachexia, Fatigue, Pulmonary Complications

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
exercise intervention
pulmonary complications management/prevention
quality-of-life assessment
questionnaire administration
Sponsored by
Ohio State University Comprehensive Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cachexia focused on measuring Pulmonary Rehabilitation, Non-Small Cell Lung Cancer, NSCLC

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who have been diagnosed with locally advanced unresectable NSCLC undergoing definite chemo-radiation with curative intent
  • Patients must be able to sign informed consent
  • Patients who qualify for pulmonary rehabilitation as part of the standard of care and are covered by medical insurance
  • Patients must be able to ambulate a minimum of 100 feet prior to enrollment in pulmonary rehab
  • Patients must be willing and able to travel to the pulmonary rehabilitation site at the Morehouse Medical Plaza

Exclusion Criteria:

  • Tumor resection candidates
  • If survival is deemed less than 6 months for any medical condition
  • If they have angina or unstable coronary disease
  • Congestive heart failure refractory to medical management
  • Malignancy with bone instability
  • Inmates

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Arm I (early intervention)

    Arm II (late intervention)

    Arm Description

    Beginning within 2 weeks of starting chemoradiation, patients undergo an individualized rehabilitation program comprising aerobic exercise and strength training, including treadmill walking, stationary bicycle, NU-Step, upper body resistance training and breathing retraining, 3 times per week for 8 weeks (36 sessions).

    Beginning 1 month after completion of chemoradiation, patients undergo an individualized exercise rehabilitation program as in Arm I.

    Outcomes

    Primary Outcome Measures

    Percent improvement in the 6 minute walk from prior to post PR
    Either a two-sided t-test or a Wilcoxon-rank sum test will be used to test the difference in the improvement of the 6 minute walk depending on the distribution. This test will be used to compare the difference in improvement between PR during chemo-radiation of NSCLC patients and PR 8 weeks post chemo-radiation. Linear regression will be used to estimate which clinical characteristics and patient demographics are associated with improvement in 6 minute walk. The study population will be described using means and standard deviations or medians and the interquartile range.

    Secondary Outcome Measures

    Percent improvement in the St. George Respiratory Questionnaire (SGRQ) score
    Feasibility of the program, based on number of patients attending the sessions throughout the 8 weeks
    Either Pearson's chi-square of Fisher's exact methods will be used to test if the feasibility differs across groups. Logistic regression will be used to estimate which clinical characteristics and patient demographics are associated with feasibility.

    Full Information

    First Posted
    December 17, 2013
    Last Updated
    April 12, 2017
    Sponsor
    Ohio State University Comprehensive Cancer Center
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02017925
    Brief Title
    Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
    Official Title
    Pulmonary Rehabilitation in Locally Advanced Non-Small Cell Lung Cancer
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2017
    Overall Recruitment Status
    Withdrawn
    Study Start Date
    October 2013 (undefined)
    Primary Completion Date
    March 2017 (Anticipated)
    Study Completion Date
    March 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Ohio State University Comprehensive Cancer Center

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    This randomized clinical trial studies pulmonary rehabilitation in improving lung function in patients with locally advanced non-small cell lung cancer undergoing chemoradiation. Individualized exercise rehabilitation programs may reduce breathing problems and improve quality of life in patients with non-small cell lung cancer. It is not yet known whether pulmonary rehabilitation is more effective when started during or after cancer treatment.
    Detailed Description
    PRIMARY OBJECTIVES: I. To determine feasibility of pulmonary rehabilitation (PR) in patients with locally advanced unresectable non-small cell lung cancer (NSCLC) undergoing definite chemotherapy and radiation therapy. II. To measure exercise capacity and respiratory symptoms in lung cancer patients receiving chemotherapy and radiation before and after pulmonary rehabilitation. III. To compare if there are any differences in symptom relief, exercise capacity, and cancer treatment tolerability between performing pulmonary rehabilitation during chemo-radiation versus after completion of lung cancer treatment. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Beginning within 2 weeks of starting chemoradiation, patients undergo an individualized rehabilitation program comprising aerobic exercise and strength training, including treadmill walking, stationary bicycle, NU-Step, upper body resistance training and breathing retraining, 3 times per week for 8 weeks (36 sessions). ARM II: Beginning 1 month after completion of chemoradiation, patients undergo an individualized exercise rehabilitation program as in Arm I.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cachexia, Fatigue, Pulmonary Complications, Radiation Toxicity, Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Keywords
    Pulmonary Rehabilitation, Non-Small Cell Lung Cancer, NSCLC

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Arm I (early intervention)
    Arm Type
    Experimental
    Arm Description
    Beginning within 2 weeks of starting chemoradiation, patients undergo an individualized rehabilitation program comprising aerobic exercise and strength training, including treadmill walking, stationary bicycle, NU-Step, upper body resistance training and breathing retraining, 3 times per week for 8 weeks (36 sessions).
    Arm Title
    Arm II (late intervention)
    Arm Type
    Experimental
    Arm Description
    Beginning 1 month after completion of chemoradiation, patients undergo an individualized exercise rehabilitation program as in Arm I.
    Intervention Type
    Behavioral
    Intervention Name(s)
    exercise intervention
    Intervention Description
    Undergo pulmonary rehabilitation
    Intervention Type
    Procedure
    Intervention Name(s)
    pulmonary complications management/prevention
    Intervention Description
    Undergo pulmonary rehabilitation
    Intervention Type
    Procedure
    Intervention Name(s)
    quality-of-life assessment
    Other Intervention Name(s)
    quality of life assessment
    Intervention Description
    Ancillary studies
    Intervention Type
    Other
    Intervention Name(s)
    questionnaire administration
    Intervention Description
    Ancillary studies
    Primary Outcome Measure Information:
    Title
    Percent improvement in the 6 minute walk from prior to post PR
    Description
    Either a two-sided t-test or a Wilcoxon-rank sum test will be used to test the difference in the improvement of the 6 minute walk depending on the distribution. This test will be used to compare the difference in improvement between PR during chemo-radiation of NSCLC patients and PR 8 weeks post chemo-radiation. Linear regression will be used to estimate which clinical characteristics and patient demographics are associated with improvement in 6 minute walk. The study population will be described using means and standard deviations or medians and the interquartile range.
    Time Frame
    Baseline to up to 8 weeks
    Secondary Outcome Measure Information:
    Title
    Percent improvement in the St. George Respiratory Questionnaire (SGRQ) score
    Time Frame
    Baseline to up to 8 weeks
    Title
    Feasibility of the program, based on number of patients attending the sessions throughout the 8 weeks
    Description
    Either Pearson's chi-square of Fisher's exact methods will be used to test if the feasibility differs across groups. Logistic regression will be used to estimate which clinical characteristics and patient demographics are associated with feasibility.
    Time Frame
    Up to 8 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients who have been diagnosed with locally advanced unresectable NSCLC undergoing definite chemo-radiation with curative intent Patients must be able to sign informed consent Patients who qualify for pulmonary rehabilitation as part of the standard of care and are covered by medical insurance Patients must be able to ambulate a minimum of 100 feet prior to enrollment in pulmonary rehab Patients must be willing and able to travel to the pulmonary rehabilitation site at the Morehouse Medical Plaza Exclusion Criteria: Tumor resection candidates If survival is deemed less than 6 months for any medical condition If they have angina or unstable coronary disease Congestive heart failure refractory to medical management Malignancy with bone instability Inmates
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Patrick Nana-Sinkam, MD
    Organizational Affiliation
    Ohio State University Comprehensive Cancer Center
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Links:
    URL
    http://cancer.osu.edu
    Description
    The Jamesline

    Learn more about this trial

    Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation

    We'll reach out to this number within 24 hrs